F.D.A. Advisers Endorse Paxlovid’s Benefits as a Covid Treatment

While an agency analysis did find signs of Covid “rebound,” the drug significantly reduces hospitalizations and deaths, researchers said.

source https://www.nytimes.com/2023/03/16/health/fda-paxlovid-covid.html